(Q40752705)

23 September 2017

1 reference

title

Current perspectives on sudden cardiac death in hypertrophic cardiomyopathy (English)

1 reference

23 September 2017

DeRose JJ Jr

1

1 reference

23 September 2017

Banas JS Jr

series ordinal

2

1 reference

23 September 2017

Winters SL

series ordinal

3

1 reference

23 September 2017

publication date

1 May 1994

1 reference

Progress in Cardiovascular Diseases

23 September 2017

published in

1 reference

23 September 2017

volume

36

1 reference

23 September 2017

issue

6

1 reference

23 September 2017

page(s)

475-484

1 reference

Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Idiopathic hypertrophic subaortic stenosis. Clinical analysis of 126 patients with emphasis on the natural history

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Hypertrophic cardiomyopathy: an important cause of sudden death

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1).

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (2).

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Human ventricular repolarization and T wave genesis

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Genetic evidence of dissociation (generational skips) of electrical from morphologic forms of hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Hypertrophic cardiomyopathy and sudden death

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Hemodynamic and electrophysiologic evaluation of patients with hypertrophic cardiomyopathy surviving cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Sudden death in hypertrophic cardiomyopathy. Assessment of patients at high risk

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Relation of left ventricular function and prognosis in hypertrophic cardiomyopathy: an angiographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. A consecutive analysis in 155 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Arrhythmia and prognosis in infants, children and adolescents with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Electrophysiologic testing in the management of survivors of out-of-hospital cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Long-term follow-up of patients with recurrent unexplained syncope evaluated by electrophysiologic testing

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Electrophysiologic studies of patients with hypertrophic cardiomyopathy presenting with syncope of undetermined etiology

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Inducible polymorphic ventricular tachycardia and ventricular fibrillation in a subgroup of patients with hypertrophic cardiomyopathy at high risk for sudden death

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Value of programmed electrical stimulation using a standardized ventricular stimulation protocol in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Programmed electrical stimulation in hypertrophic cardiomyopathy. Results in patients with and without cardiac arrest or syncope

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Electrophysiologic evaluation of patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Fast-Fourier transform analysis of signal-averaged electrocardiograms for identification of patients prone to sustained ventricular tachycardia.

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Prognostic significance of ventricular tachycardia and fibrillation induced at programmed stimulation and delayed potentials detected on the signal-averaged electrocardiograms of survivors of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

A new noninvasive index to predict sustained ventricular tachycardia and sudden death in the first year after myocardial infarction: based on signal-averaged electrocardiogram, radionuclide ejection fraction and Holter monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Prediction of serious arrhythmic events after myocardial infarction: signal-averaged electrocardiogram, Holter monitoring and radionuclide ventriculography

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Signal-averaged electrocardiography in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

The prevalence of arrhythmias in hypertrophic cardiomyopathy: role of ambulatory monitoring and signal-averaged electrocardiography

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Late ventricular potentials and spontaneous and induced ventricular arrhythmias in dilated or hypertrophic cardiomyopathies. A prospective study about 83 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

A comparative study of frequency domain and time domain analysis of signal-averaged electrocardiograms in patients with ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

“Malignant” hypertrophic cardiomyopathy: Identification of a subgroup of families with unusually frequent premature death

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Localization of gene for familial hypertrophic cardiomyopathy to chromosome 14q1 in a diverse US population

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Familial hypertrophic cardiomyopathy is a genetically heterogeneous disease

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Long-term medical management of hypertrophic obstructive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Management of hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Use of calcium-channel blocking drugs in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: a retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Hypertrophic cardiomyopathy: long-term effects of propranolol versus verapamil in preventing sudden death in "low-risk" patients

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Oral disopyramide therapy for obstructive hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Hypertrophic cardiomyopathy: Prognosis with medical or surgical therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Sudden death during empiric amiodarone therapy in symptomatic hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Value of electrophysiologic studies in hypertrophic cardiomyopathy treated with amiodarone

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Amiodarone-induced complications after cardiac operation for obstructive hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Symptomatic status and prognosis of patients after operation for hypertrophic obstructive cardiomyopathy: efficacy of ventricular septal myotomy and myectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

QT dispersion: an indication of arrhythmia risk in patients with long QT intervals

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

Heart rate variability

1 reference

https://api.crossref.org/works/10.1016%2FS0033-0620%2894%2980054-5

7 January 2021

10.1016/S0033-0620(94)80054-5

Identifiers

DOI

1 reference

23 September 2017

1 reference